United States Healthcare Equipment & Supplies

Myriad Genetics Inc (MYGN)

Track

Over the past 90 days, Myriad Genetics Inc. recorded four insider transactions, resulting in a net value of $27,637.50. Activity included a buy by Paul Bisaro in May, alongside planned sales by director Rashmi Kumar in June. These transactions follow a recent earnings report that missed EPS expectations by 28.57%.
Ticker: MYGN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Myriad Genetics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 8 Jun 2026
Value US$891,621.47 | Price 493.24 | Shares 98,869 (-33.9%)
Planned sale 8 Jun 2026
Value US$4,551,702.41 | Price 303.72 | Shares 62,364 (+26.3%)
Proposed sale 8 Jun 2026
Value US$68,850.00 | Price 4.59 | Shares 15,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-09 2026-06-08 PlS Planned sale
Kumar Rashmi
Non-Executive Director
98,869 -33.9%
493.24
US$891,621 		98,869 -33.9% 493.24 US$891,621
2026-06-09 2026-06-08 PlS Planned sale
Kumar Rashmi
Non-Executive Director
62,364 +26.3%
303.72
US$4,551,702 		62,364 +26.3% 303.72 US$4,551,702
2026-06-08 2026-06-08 PrS Proposed sale
Kumar Rashmi

Director

Non-Executive Director
3,246
495.48
US$1,176,621 		3,246 495.48 US$1,176,621
2026-05-14 2026-05-14 B Purchase
2.3
Bisaro Paul
Non-Executive Director
7,500 +8.3%
3.69
US$27,638 		7,500 +8.3% 3.69 US$27,638
2026-03-09 2026-03-09 B Purchase
1.8
Raha Samraat S.

President and CEO

Executive Director
40,000 +8.8%
5.00
US$199,844 		40,000 +8.8% 5.00 US$199,844
2026-02-27 2026-02-27 B Purchase
3.7
Phanstiel S. Louise
Non-Executive Director
48,000 +20.5%
4.66
US$223,728 		48,000 +20.5% 4.66 US$223,728
2026-02-27 2026-02-26 B Purchase
3.7
Phanstiel S. Louise
Non-Executive Director
50,407 +27.5%
4.80
US$242,105 		50,407 +27.5% 4.80 US$242,105
2026-02-27 2026-02-25 B Purchase
3.7
Phanstiel S. Louise
Non-Executive Director
6,100 +3.4%
4.74
US$28,890 		6,100 +3.4% 4.74 US$28,890
2024-10-11 2024-10-11 PrS Proposed sale
2.3
DIAZ PAUL J

Officer; Director

Executive Director
15,000
22.93
US$343,950 		15,000 22.93 US$343,950
2024-10-11 2024-10-11 PlS Planned sale
2.3
DIAZ PAUL J

President and CEO

Executive Director
15,000 -1.5%
22.93
US$343,950 		15,000 -1.5% 22.93 US$343,950
2024-09-12 2024-09-11 PlS Planned sale
2.3
DIAZ PAUL J

President and CEO

Executive Director
15,000 -1.5%
26.72
US$400,800 		15,000 -1.5% 26.72 US$400,800
2024-09-12 2024-09-11 S Sale
3.2
Muzzey Dale

Chief Scientific Officer

Officer
2,100 -1.9%
26.17
US$54,961 		2,100 -1.9% 26.17 US$54,961
2024-09-11 2024-09-11 PrS Proposed sale
3.2
Muzzey Dale

Officer

Officer
2,100
26.17
US$54,961 		2,100 26.17 US$54,961
2024-09-11 2024-09-11 PrS Proposed sale
2.3
DIAZ PAUL J

Officer; Director

Executive Director
15,000
26.72
US$400,800 		15,000 26.72 US$400,800
2024-09-09 2024-09-10 PrS Proposed sale
3.2
Dreismann Heinrich

Director

Non-Executive Director
10,000
27.00
US$270,000 		10,000 27.00 US$270,000
2024-09-09 2024-09-09 S Sale
3.2
Dreismann Heinrich
Non-Executive Director
10,000 -7.6%
27.05
US$270,520 		10,000 -7.6% 27.05 US$270,520
2024-09-04 2024-09-03 PlS Planned sale
1.1
Reitan Colleen F
Non-Executive Director
46,012 -52.0%
27.95
US$1,285,851 		46,012 -52.0% 27.95 US$1,285,851
2024-09-03 2024-09-03 PrS Proposed sale
1.1
Reitan Colleen F

Director

Non-Executive Director
46,012
28.19
US$1,297,078 		46,012 28.19 US$1,297,078
2024-09-16 2024-08-21 PrS Proposed sale
3.0
Ancona Margaret

Officer

Officer
11,538
27.82
US$321,019 		11,538 27.82 US$321,019
2024-08-23 2024-08-21 S Sale
3.0
Ancona Margaret

SVP, Chief of Staff

Officer
11,538 -12.7%
27.82
US$320,987 		11,538 -12.7% 27.82 US$320,987
2024-08-20 2024-08-19 PlS Planned sale
Kumar Rashmi
Non-Executive Director
7,500 -8.8%
28.01
US$210,075 		7,500 -8.8% 28.01 US$210,075
2024-08-19 2024-08-19 PrS Proposed sale
Kumar Rashmi

Director

Non-Executive Director
7,500
28.01
US$210,075 		7,500 28.01 US$210,075
2024-06-04 2024-06-04 PrS Proposed sale
SPIEGELMAN DANIEL K

Director

Non-Executive Director
3,788
22.05
US$83,525 		3,788 22.05 US$83,525
2024-06-04 2024-06-04 PlS Planned sale
SPIEGELMAN DANIEL K
Non-Executive Director
3,788 -10.3%
22.05
US$83,525 		3,788 -10.3% 22.05 US$83,525
2024-06-04 2024-06-03 PlS Planned sale
SPIEGELMAN DANIEL K
Non-Executive Director
3,788 -9.4%
22.04
US$83,488 		3,788 -9.4% 22.04 US$83,488
2024-06-03 2024-06-03 PrS Proposed sale
SPIEGELMAN DANIEL K

Director

Non-Executive Director
3,788
22.04
US$83,488 		3,788 22.04 US$83,488
2024-05-15 2024-05-15 PrS Proposed sale
2.3
DIAZ PAUL J

Officer; Director

Executive Director
75,000
25.07
US$1,880,414 		75,000 25.07 US$1,880,414
2024-05-15 2024-05-15 S Sale
2.3
DIAZ PAUL J

President and CEO

Executive Director
75,000 -6.6%
25.07
US$1,880,415 		75,000 -6.6% 25.07 US$1,880,415
2024-05-15 2024-05-14 S Sale
2.3
DIAZ PAUL J

President and CEO

Executive Director
95,000 -7.7%
25.21
US$2,394,798 		95,000 -7.7% 25.21 US$2,394,798
2024-05-14 2024-05-14 PrS Proposed sale
2.3
DIAZ PAUL J

Officer; Director

Executive Director
95,000
25.21
US$2,394,799 		95,000 25.21 US$2,394,799
2024-05-15 2024-05-13 S Sale
1.6
Newcomer Lee Nisley
Non-Executive Director
6,200 -8.5%
25.30
US$156,860 		6,200 -8.5% 25.30 US$156,860
2024-05-15 2024-05-13 S Sale
2.3
DIAZ PAUL J

President and CEO

Executive Director
57,844 -4.5%
25.13
US$1,453,550 		57,844 -4.5% 25.13 US$1,453,550
2024-05-13 2024-05-13 PrS Proposed sale
2.3
DIAZ PAUL J

Officer; Director

Executive Director
57,844
25.13
US$1,453,552 		57,844 25.13 US$1,453,552
2024-05-13 2024-05-13 PrS Proposed sale
1.6
Newcomer Lee Nisley

Director

Non-Executive Director
6,200
25.30
US$156,862 		6,200 25.30 US$156,862
2024-04-10 2024-04-10 PrS Proposed sale
Richard Bryan Riggsbee

Affiliate
75,000
20.02
US$1,501,500 		75,000 20.02 US$1,501,500
2023-12-05 2023-12-01 PlS Planned sale
Riggsbee Richard Bryan

Chief Financial Officer

Officer
30,000 -9.3%
19.09
US$572,835 		30,000 -9.3% 19.09 US$572,835
2023-11-03 2023-11-01 PlS Planned sale
Riggsbee Richard Bryan

Chief Financial Officer

Officer
30,000 -8.5%
15.69
US$470,622 		30,000 -8.5% 15.69 US$470,622
2023-11-01 2023-11-01 PrS Proposed sale
Richard Bryan Riggsbee

Officer

Officer
60,000
15.55
US$933,000 		60,000 15.55 US$933,000
2023-06-02 2023-06-02 PrS Proposed sale
SPIEGELMAN DANIEL K

Director

Non-Executive Director
8,638
23.01
US$198,760 		8,638 23.01 US$198,760
2023-06-02 2023-06-02 PlS Planned sale
SPIEGELMAN DANIEL K
Non-Executive Director
8,638 -17.6%
23.01
US$198,760 		8,638 -17.6% 23.01 US$198,760
2023-03-28 2023-03-27 PlS Planned sale
3.3
Lambert Nicole

Chief Operating Officer

Officer
6,433 -2.6%
23.48
US$151,047 		6,433 -2.6% 23.48 US$151,047
2023-03-27 2023-03-27 PrS Proposed sale
3.3
Lambert Nicole

Officer

Officer
6,433
23.48
US$151,047 		6,433 23.48 US$151,047
2023-03-03 2023-03-02 PlS Planned sale
3.3
Lambert Nicole

Chief Operating Officer

Officer
13,184 -5.8%
22.74
US$299,823 		13,184 -5.8% 22.74 US$299,823
2023-03-03 2023-03-02 PlS Planned sale
Riggsbee Richard Bryan

Chief Financial Officer

Officer
15,000 -4.3%
22.55
US$338,253 		15,000 -4.3% 22.55 US$338,253
2023-03-02 2023-03-02 PrS Proposed sale
3.3
Lambert Nicole

Officer

Officer
13,184
22.74
US$299,822 		13,184 22.74 US$299,822
2023-01-23 2023-01-20 PlS Planned sale
Riggsbee Richard Bryan

Chief Financial Officer

Officer
9,400 -2.5%
20.04
US$188,386 		9,400 -2.5% 20.04 US$188,386
2023-01-19 2023-01-18 PlS Planned sale
Riggsbee Richard Bryan

Chief Financial Officer

Officer
600 -0.2%
20.01
US$12,006 		600 -0.2% 20.01 US$12,006
2022-12-28 2022-12-27 PlS Planned sale
Riggsbee Richard Bryan

Chief Financial Officer

Officer
20,000 -5.1%
15.15
US$302,992 		20,000 -5.1% 15.15 US$302,992
2022-06-06 2022-06-06 PlS Planned sale
SPIEGELMAN DANIEL K
Non-Executive Director
6,424 -15.9%
19.25
US$123,673 		6,424 -15.9% 19.25 US$123,673
2022-03-01 2022-02-28 PlS Planned sale
Hart Jayne B.

Chief People Officer

Officer
3,500 -2.1%
25.00
US$87,500 		3,500 -2.1% 25.00 US$87,500
2022-03-01 2022-02-28 PlS Planned sale
Hart Jayne B.

Chief People Officer

Officer
7,000 -4.0%
25.00
US$175,000 		7,000 -4.0% 25.00 US$175,000
2021-10-04 2021-10-01 PlS Planned sale
3.3
Lambert Nicole

See Remarks

Officer
1,420 -0.8%
31.57
US$44,835 		1,420 -0.8% 31.57 US$44,835
2021-09-27 2021-09-27 PlS Planned sale
3.3
Lambert Nicole

See Remarks

Officer
10,112 -5.4%
33.10
US$334,747 		10,112 -5.4% 33.10 US$334,747
2021-09-27 2021-09-23 PlS Planned sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
200 -0.1%
35.06
US$7,012 		200 -0.1% 35.06 US$7,012
2021-08-05 2021-08-04 PlS Planned sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
11,775 -4.8%
35.57
US$418,856 		11,775 -4.8% 35.57 US$418,856
2021-08-05 2021-08-04 PlS Planned sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
38,225 -14.1%
35.24
US$1,347,171 		38,225 -14.1% 35.24 US$1,347,171
2021-08-05 2021-08-03 PlS Planned sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
4,170 -1.8%
34.00
US$141,780 		4,170 -1.8% 34.00 US$141,780
2021-08-05 2021-08-03 PlS Planned sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
27,830 -10.7%
34.00
US$946,220 		27,830 -10.7% 34.00 US$946,220
2021-08-05 2021-08-03 PlS Planned sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
1,775 -0.8%
35.07
US$62,249 		1,775 -0.8% 35.07 US$62,249
2021-08-05 2021-08-03 PlS Planned sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
16,225 -6.5%
33.99
US$551,488 		16,225 -6.5% 33.99 US$551,488
2021-06-28 2021-06-25 PlS Planned sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
33,372 -12.5%
31.61
US$1,055,036 		33,372 -12.5% 31.61 US$1,055,036
2021-06-28 2021-06-25 PlS Planned sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
28,640 -9.7%
31.97
US$915,621 		28,640 -9.7% 31.97 US$915,621
2021-06-28 2021-06-25 PlS Planned sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
21,360 -7.4%
32.47
US$693,559 		21,360 -7.4% 32.47 US$693,559
2021-06-17 2021-06-17 PlS Planned sale
SPIEGELMAN DANIEL K
Non-Executive Director
3,139 -11.9%
30.52
US$95,795 		3,139 -11.9% 30.52 US$95,795
2021-06-01 2021-05-28 PlS Planned sale
SPIEGELMAN DANIEL K
Non-Executive Director
7,142 -34.7%
28.99
US$207,023 		7,142 -34.7% 28.99 US$207,023
2021-05-05 2021-05-04 PlS Planned sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
19,360 -6.8%
31.97
US$618,949 		19,360 -6.8% 31.97 US$618,949
2021-04-28 2021-04-27 PlS Planned sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
40,000 -13.1%
31.47
US$1,258,800 		40,000 -13.1% 31.47 US$1,258,800
2021-03-30 2021-03-29 PlS Planned sale
Hart Jayne B.

Chief People Officer

Officer
8,034 -9.1%
30.00
US$241,020 		8,034 -9.1% 30.00 US$241,020
2021-03-30 2021-03-29 PlS Planned sale
Hart Jayne B.

Chief People Officer

Officer
21,966 -21.5%
30.00
US$658,980 		21,966 -21.5% 30.00 US$658,980
2021-03-30 2021-03-29 PlS Planned sale
Hart Jayne B.

Chief People Officer

Officer
28,000 -25.9%
30.00
US$840,000 		28,000 -25.9% 30.00 US$840,000
2021-02-17 2021-02-16 S Sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
5,555 -2.2%
29.71
US$165,056 		5,555 -2.2% 29.71 US$165,056
2021-02-17 2021-02-16 S Sale
2.2
LANCHBURY JERRY S

Chief Scientific Officer

Officer
74,445 -23.2%
29.71
US$2,211,992 		74,445 -23.2% 29.71 US$2,211,992
2021-01-11 2021-01-08 PlS Planned sale
Parkinson Paul

EVP Strategy and Innovation

Officer
11,824 -13.3%
25.00
US$295,600 		11,824 -13.3% 25.00 US$295,600
2020-11-12 2020-11-11 B Purchase
3.7
Phanstiel S. Louise
Non-Executive Director
15,000 +29.0%
16.62
US$249,336 		15,000 +29.0% 16.62 US$249,336
2020-09-16 2020-09-15 S Sale
1.4
Ford Alexander

Chief Operating Officer

Officer
2,804 -1.8%
13.78
US$38,630 		2,804 -1.8% 13.78 US$38,630
Explore more

More insider trading research around Myriad Genetics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America